Matthias Aizenberg

The intersection of artificial intelligence (AI) and bioprocess development has paved the way for groundbreaking advancements in the life sciences sector. One particularly exciting development in this domain is the collaboration between Eppendorf SE, a leading life sciences company, and DataHow AG,

The subject of this article is the significant strides made in genetic research that have led to the diagnosis of over 500 European patients with rare and previously undiagnosed conditions. This includes uncovering the roots of rare neurological disorders, severe intellectual disabilities, muscle

Recent revelations have unveiled a deeply troubling scenario for NHS nurses and patients alike, highlighting the alarming extent to which healthcare professionals are being forced to operate in perilous and overcrowded conditions. A comprehensive report from the Royal College of Nursing (RCN) has

Researchers from the Stevens Institute of Technology have developed an advanced software tool named "clipping spline," which offers unprecedented capabilities for viewing and analyzing complex 3D biomedical images. This innovation enables deep and comprehensive visualization of optical

The Perelman School of Medicine at the University of Pennsylvania has introduced a revolutionary tool named MISO (Multi-modal Spatial Omics), which leverages artificial intelligence to significantly improve the detection and analysis of cell-level characteristics in cancer. This innovative tool

Makerere University in Kampala, Uganda recently unveiled a groundbreaking initiative during its 75th graduation ceremony, targeting enhanced security measures for laboratory safety and administrative protocols. In collaboration with the Uganda Virus Research Institute (UVRI) and backed by the

Osteosarcoma, a rare and aggressive bone cancer, primarily affects children and young adults during periods of rapid bone growth. Despite its rarity, the impact of osteosarcoma is devastating, often requiring surgery or amputation and posing a high risk of metastasis to the lungs. For decades, the

The field of oncology has witnessed numerous advancements over the years, but the introduction of molecular glue degraders marks a significant leap forward. These innovative small molecules are poised to transform cancer treatment by targeting previously "undruggable" proteins, offering

Aneuploidy, the presence of an abnormal number of chromosomes within a cell, is widely recognized as a defining hallmark of cancer. This association has guided cancer diagnostics and research for years, embedding in the scientific community's understanding of how cancers develop and progress.

The field of synthetic biology has witnessed a groundbreaking development with the advent of "DNA origami," a technique that allows scientists to control the structure and function of biological membranes. This innovation, spearheaded by Professor Laura Na Liu and her team at the